A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Akeso
Related studies linked through entity extraction aliases.
AK135 in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
AK112 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/ Metastatic Triple-negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of AK120 in Subjects With Moderate to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
AK137 (Bispecific Antibody Targeting CD73 and LAG-3) in Patients With Advanced Malignant Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
AK112 and Cadonilimab Combined With Chemotherapy for 1L Treatment of Metastatic Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of AK129 With or Without AK117 in PD(L)1-refractory Classic Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Chinese Healthy Male Subjects
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC
- Status
- RECRUITING
- Phase
- PHASE3
A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
- Status
- RECRUITING
- Phase
- PHASE3
AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Anti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ Adenocarcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase III Study of AK112 for NSCLC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of AK117 in Combination With Azactidine Plus Venetoclax in Patients With Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2